Literature DB >> 7097855

UV irradiation analysis of complementation between, and replication of, RNA-negative temperature-sensitive mutants of Newcastle disease virus.

M E Peeples, M A Bratt.   

Abstract

Random UV irradiation-induced lesions destroy the infectivity of Newcastle disease virus (NDV) by blocking downstream transcription from the single viral promoter. The nucleocapsid-associated polypeptides most likely to be involved in RNA synthesis are located at the extreme ends of the genome: NP and P are promoter proximal genes, and L is the most distal gene. We attempted to order the two temperature-sensitive (ts) RNA-negative (RNA-) mutant groups of NDV by determining the UV target sizes for the complementing abilities of mutants A1 and E1. After UV irradiation, E1 was unable to complement A1, a result compatible with the A mutation lying in the L gene. In contrast, after UV irradiation, A1 was able to complement E1 for both virus production and viral protein synthesis, with a target size most consistent with the E mutation lying in the P gene. UV-irradiated virus was unable to replicate as indicated by its absence in the yields of multiply infected cells, either as infectious virus or as particles with complementing activity. After irradiation, ts mutant B1 delta P, with a non-ts mutation affecting the electrophoretic mobility of the P protein, complemented E1 in a manner similar to A1, but it did not amplify the expression of delta P in infected cells. This too is consistent with irradiated virus being unable to replicate despite the presence of the components needed for replication of E1. At high UV doses, A1 was able to complement E1 in a different, UV-resistant manner, probably by direct donation of input polypeptides. Multiplicity reactivation has previously been observed at high-multiplicity infection by UV-irradiation paramyxoviruses. In this case, virions which are noninfectious because they lack a protein component may be activated by a protein from irradiation virions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7097855      PMCID: PMC256833          DOI: 10.1128/JVI.41.3.965-973.1982

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Multiplicity reactivation of Newcastle disease virus.

Authors:  J W DRAKE
Journal:  J Bacteriol       Date:  1962-08       Impact factor: 3.490

2.  Studies on mixed infection with Newcastle disease virus. III. Activation of nonplaque-forming virus by plaque-forming virus.

Authors:  A GRANOFF
Journal:  Virology       Date:  1961-05       Impact factor: 3.616

3.  Studies on mixed infection with Newcastle disease virus. II. The occurrence of Newcastle disease virus heterozygotes and study of phenotypic mixing involving serotype and thermal stability.

Authors:  A GRANOFF
Journal:  Virology       Date:  1959-12       Impact factor: 3.616

4.  Parental G protein reincorporation by a vesicular stomatitis virus temperature-sensitive mutant of complementation group V at nonpermissive temperature.

Authors:  V Deutsch
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Polyadenylate sequences on Newcastle disease virus mRNA synthesized in vivo and in vitro.

Authors:  S R Weiss; M A Bratt
Journal:  J Virol       Date:  1974-06       Impact factor: 5.103

7.  Protein synthesis in Newcastle disease virus-infected chicken embryo cells.

Authors:  L E Hightower; M A Bratt
Journal:  J Virol       Date:  1974-04       Impact factor: 5.103

8.  Isolation of a transcriptive complex from Newcastle disease virions.

Authors:  R J Colonno; H O Stone
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

9.  Synthesis, stability, and cleavage of Newcastle disease virus glycoproteins in the absence of glycosylation.

Authors:  T G Morrison; D Simpson
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

10.  Noncytopathic mutants of Newcastle disease virus are defective in virus-specific RNA synthesis.

Authors:  C H Madansky; M A Bratt
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

View more
  9 in total

1.  Conformational change in a viral glycoprotein during maturation due to disulfide bond disruption.

Authors:  T G Morrison; M E Peeples; L W McGinnes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

2.  Conformational changes in Newcastle disease virus fusion glycoprotein during intracellular transport.

Authors:  L W McGinnes; A Semerjian; T Morrison
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

3.  Mutation in the matrix protein of Newcastle disease virus can result in decreased fusion glycoprotein incorporation into particles and decreased infectivity.

Authors:  M E Peeples; M A Bratt
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

4.  Intracellular processing of the Newcastle disease virus fusion glycoprotein.

Authors:  T Morrison; L J Ward; A Semerjian
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Thermostabilities of virion activities of Newcastle disease virus: evidence that the temperature-sensitive mutants in complementation groups B, BC, and C have altered HN proteins.

Authors:  M E Peeples; R L Glickman; M A Bratt
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

6.  RNA synthesis by Newcastle disease virus temperature-sensitive mutants in two RNA-negative complementation groups.

Authors:  M E Peeples; L L Rasenas; M A Bratt
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

7.  Virion functions of RNA+ temperature-sensitive mutants of Newcastle disease virus.

Authors:  M E Peeples; M A Bratt
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

8.  Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein.

Authors:  R M Iorio; M A Bratt
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

9.  Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro.

Authors:  Andrew P Cap; Heather F Pidcoke; Shawn D Keil; Hilary M Staples; Manu Anantpadma; Ricardo Carrion; Robert A Davey; Ashley Frazer-Abel; Audra L Taylor; Richard Gonzales; Jean L Patterson; Raymond P Goodrich
Journal:  Transfusion       Date:  2016-03       Impact factor: 3.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.